# OrdersSharesBidAskShares# Orders

Although the volume is low the pressure is building on the bid side, the share ratio 6:1 buy to sell. It just goes to show the Day trading is all but dried up and as we go sideways here the volume on the buyers side is starting to build. This indicates to me, fewer retail investers are willing to move when somebody shakes the tree. All the loose traders have taken their profit and moved on. Long and strong. I was down and out two years ago and now our little Canadian Bioteck company is leaving it's imprint on every Conference it attends.

I can't help but wonder what the hold up is on the approval of the next round of testing with the FDA. Would it be the fact that the Clevland Clinic is not involved after the last issue with the release of the Assure trial results? Did Don have a falling out with them and this has filtered back to the FDA? Could there be corporate politices involved? Nissen came out as strongly infavor of the PSK trial and review. Just my thoughts.